vs

Side-by-side financial comparison of Capital Bancorp Inc (CBNK) and GERON CORP (GERN). Click either name above to swap in a different company.

Capital Bancorp Inc is the larger business by last-quarter revenue ($62.7M vs $47.2M, roughly 1.3× GERON CORP). On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 11.6%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 23.7%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

CBNK vs GERN — Head-to-Head

Bigger by revenue
CBNK
CBNK
1.3× larger
CBNK
$62.7M
$47.2M
GERN
Growing faster (revenue YoY)
GERN
GERN
+55.5% gap
GERN
67.1%
11.6%
CBNK
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
23.7%
CBNK

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
CBNK
CBNK
GERN
GERN
Revenue
$62.7M
$47.2M
Net Profit
$-18.4M
Gross Margin
Operating Margin
31.4%
-29.4%
Net Margin
-39.0%
Revenue YoY
11.6%
67.1%
Net Profit YoY
30.3%
EPS (diluted)
$0.92
$-0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBNK
CBNK
GERN
GERN
Q4 25
$62.7M
Q3 25
$63.1M
$47.2M
Q2 25
$60.8M
$49.0M
Q1 25
$58.6M
$39.6M
Q4 24
$56.2M
Q3 24
$45.0M
$28.3M
Q2 24
$43.9M
$882.0K
Q1 24
$41.0M
$304.0K
Net Profit
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
$15.1M
$-18.4M
Q2 25
$13.1M
$-16.4M
Q1 25
$13.9M
$-19.8M
Q4 24
Q3 24
$8.7M
$-26.4M
Q2 24
$8.2M
$-67.4M
Q1 24
$6.6M
$-55.4M
Operating Margin
CBNK
CBNK
GERN
GERN
Q4 25
31.4%
Q3 25
-1.5%
-29.4%
Q2 25
-1.5%
-25.4%
Q1 25
-1.5%
-42.2%
Q4 24
-2.2%
Q3 24
-2.2%
-99.8%
Q2 24
-1.8%
-7860.9%
Q1 24
-2.3%
-18465.1%
Net Margin
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
23.9%
-39.0%
Q2 25
21.6%
-33.4%
Q1 25
23.8%
-50.1%
Q4 24
Q3 24
19.3%
-93.5%
Q2 24
18.7%
-7639.8%
Q1 24
16.0%
-18220.4%
EPS (diluted)
CBNK
CBNK
GERN
GERN
Q4 25
$0.92
Q3 25
$0.89
$-0.03
Q2 25
$0.78
$-0.02
Q1 25
$0.82
$-0.03
Q4 24
$0.44
Q3 24
$0.62
$-0.04
Q2 24
$0.59
$-0.10
Q1 24
$0.47
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBNK
CBNK
GERN
GERN
Cash + ST InvestmentsLiquidity on hand
$78.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$401.8M
$248.7M
Total Assets
$3.6B
$567.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
$78.1M
Q2 25
$77.7M
Q1 25
$83.7M
Q4 24
Q3 24
$60.3M
Q2 24
$116.9M
Q1 24
$189.8M
Stockholders' Equity
CBNK
CBNK
GERN
GERN
Q4 25
$401.8M
Q3 25
$394.8M
$248.7M
Q2 25
$380.0M
$259.5M
Q1 25
$369.6M
$268.2M
Q4 24
$355.1M
Q3 24
$280.1M
$292.3M
Q2 24
$267.9M
$306.7M
Q1 24
$259.5M
$344.9M
Total Assets
CBNK
CBNK
GERN
GERN
Q4 25
$3.6B
Q3 25
$3.4B
$567.4M
Q2 25
$3.4B
$555.2M
Q1 25
$3.3B
$562.5M
Q4 24
$3.2B
Q3 24
$2.6B
$444.9M
Q2 24
$2.4B
$449.4M
Q1 24
$2.3B
$482.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBNK
CBNK
GERN
GERN
Operating Cash FlowLast quarter
$69.7M
$-13.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBNK
CBNK
GERN
GERN
Q4 25
$69.7M
Q3 25
$32.9M
$-13.6M
Q2 25
$-4.2M
$-27.4M
Q1 25
$22.6M
$-48.0M
Q4 24
$34.9M
Q3 24
$-464.0K
$-58.9M
Q2 24
$12.9M
$-53.5M
Q1 24
$-3.4M
$-62.3M
Free Cash Flow
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$-53.7M
Q1 24
$-62.9M
FCF Margin
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-6086.6%
Q1 24
-20680.3%
Capex Intensity
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.0%
Q2 24
23.4%
Q1 24
202.3%
Cash Conversion
CBNK
CBNK
GERN
GERN
Q4 25
Q3 25
2.18×
Q2 25
-0.32×
Q1 25
1.62×
Q4 24
Q3 24
-0.05×
Q2 24
1.57×
Q1 24
-0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons